Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Talks Resume On Recast Of Europe's Medical Device Directives

This article was originally published in The Gray Sheet

Executive Summary

After delays, the European Commission is again working on its ambitious plan to streamline medical device regulation across the European Union – though implementation of a new framework is still about five years out, speakers said at a recent regulatory affairs conference.

You may also be interested in...



Industry Calls For More Consistent European Oversight As EU Continues Reg Reform Process

Industry says it supports a more consistent approach to medical device regulation in the EU, a goal that may be advanced by the European Commission’s stated plans to revise the Medical Device Directives in the form of regulations rather than sticking with less-stringent directives.

Eucomed Q&A: Where Do EU Regs Get It Right? An Emphasis On Innovation

With U.S. medical device regulatory reforms looming, comparisons between the U.S. and European systems have become popular talking points in the debate over where FDA should be heading.

Eucomed Q&A: Where Do EU Regs Get It Right? An Emphasis On Innovation

With U.S. medical device regulatory reforms looming, comparisons between the U.S. and European systems have become popular talking points in the debate over where FDA should be heading.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT029581

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel